These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 33068861)
1. Corrigendum to "Profiling of the pattern of the human TRB/IGH-CDR3 repertoire in primary biliary cholangitis patients" [Int. Immunopharmacol. 83 (2020) 106393]. Han FF; Fang MX; Zhao DT; Dong YC; Yuan GH; Gao JE; Guo CL Int Immunopharmacol; 2020 Dec; 89(Pt B):107063. PubMed ID: 33068861 [No Abstract] [Full Text] [Related]
2. [Characteristics of IgH-CDR3 repertoire of peripheral B cells in a patient with primary biliary cholangitis: a preliminary study using high-throughput sequencing]. Zhao DT; Guo CL; Yan HP; Liao HY; Liu YM; Zhang HP; An LS; Huang CY; Han Y; Zhao Y Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):847-851. PubMed ID: 29325279 [No Abstract] [Full Text] [Related]
3. Profiling the pattern of human TRB/IGH-CDR3 repertoire in liver transplantation patients via high-throughput sequencing analysis. Han FF; Fan H; Ren LL; Wang HG; Wang C; Ma X; Liu LH; He Q; Guo CL Scand J Immunol; 2020 Aug; 92(2):e12912. PubMed ID: 32458431 [TBL] [Abstract][Full Text] [Related]
4. High-Throughput Sequencing Reveals Immunological Characteristics of the TRB-/IgH-CDR3 Region of Umbilical Cord Blood. Guo C; Wang Q; Cao X; Yang Y; Liu X; An L; Cai R; Du M; Wang G; Qiu Y; Peng Z; Han J; Ni S; Tan X; Jin L; Yu S; Wang H; Wang C; Wang X; Ma X J Pediatr; 2016 Sep; 176():69-78.e1. PubMed ID: 27373756 [TBL] [Abstract][Full Text] [Related]
5. Deep targeted sequencing reveals the diversity of TRB-CDR3 repertoire in patients with preeclampsia. Guo C; Cai R; Cao X; Yang Y; Wang Q; He R; An L; Peng Z; Chen Y; Ni S; Tan X; Han J; Liu X; Lin L; Yu S; Wang X; Wang C; Ma X Hum Immunol; 2019 Oct; 80(10):848-854. PubMed ID: 30965079 [TBL] [Abstract][Full Text] [Related]
6. High throughput sequencing reveals the diversity of TRB-CDR3 repertoire in patients with psoriasis vulgaris. Cao X; Wa Q; Wang Q; Li L; Liu X; An L; Cai R; Du M; Qiu Y; Han J; Wang C; Wang X; Guo C; Lu Y; Ma X Int Immunopharmacol; 2016 Nov; 40():487-491. PubMed ID: 27743555 [TBL] [Abstract][Full Text] [Related]
7. TCRβ repertoire of memory T cell reveals potential role for Escherichia coli in the pathogenesis of primary biliary cholangitis. Hou X; Yang Y; Chen J; Jia H; Zeng P; Lv L; Lu Y; Liu X; Diao H Liver Int; 2019 May; 39(5):956-966. PubMed ID: 30721553 [TBL] [Abstract][Full Text] [Related]
8. No difference in TCRβ repertoire of CD4+ naive T cell between patients with primary biliary cholangitis and healthy control subjects. Hou X; Zeng P; Chen J; Diao H Mol Immunol; 2019 Dec; 116():167-173. PubMed ID: 31698163 [TBL] [Abstract][Full Text] [Related]
9. Profiling the T-cell receptor repertoire of patient with pleural tuberculosis by high-throughput sequencing. Li D; Gao G; Li Z; Sun W; Li X; Chen N; Sun J; Yang Y Immunol Lett; 2014 Nov; 162(1 Pt A):170-80. PubMed ID: 25173045 [TBL] [Abstract][Full Text] [Related]
10. Corrigendum to "Asiatic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts" [Int. Immunopharmacol. 50(2017) 313-318]. Hao C; Wu B; Hou Z; Xie Q; Liao T; Wang T; Ma D Int Immunopharmacol; 2019 Jul; 72():523. PubMed ID: 31080023 [No Abstract] [Full Text] [Related]
11. Association of the characteristics of B- and T-cell repertoires with papillary thyroid carcinoma. Sun G; Qiu L; Cheng Z; Pan W; Qiu J; Zou C; Xie N; Liu S; Zhu P; Zeng J; Dai Y Oncol Lett; 2018 Aug; 16(2):1584-1592. PubMed ID: 30008841 [TBL] [Abstract][Full Text] [Related]
12. Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42]. Spadaro G; Vultaggio A; Bosi A; Reichert D; Janssen J; Lamacchia D; Nappi L; Pecoraro A; Milito C; Ferraro A; Matucci A; Bacchiarri F; Carrai V; Hibbeler A; Speckman E; Guarnieri C; Bongiovanni S; Quinti I Int Immunopharmacol; 2018 Apr; 57():201. PubMed ID: 29089244 [No Abstract] [Full Text] [Related]
13. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77]. Li F; Zhang R; Li S; Liu J Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914 [No Abstract] [Full Text] [Related]
14. Corrigendum to "Icariin targets Nrf2 signaling to inhibit microglia-mediated neuroinflammation" [Int. Immunopharmacol. 73 (2019) 304-311]. Zheng Y; Zhu G; He J; Wang G; Li D; Zhang F Int Immunopharmacol; 2020 Nov; 88():107004. PubMed ID: 32950402 [No Abstract] [Full Text] [Related]
15. Corrigendum to "Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction" [Int. Immunopharmacol. 10 (2010) 1135-1141]. Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP Int Immunopharmacol; 2019 Nov; 76():105863. PubMed ID: 31473097 [No Abstract] [Full Text] [Related]
16. Corrigendum to "Immune-enhancing effects of polysaccharides extracted from Lilium lancifolium Thunb" [Int. Immunopharmacol. 52 (2017) 119-126]. Pan G; Xie Z; Huang S; Tai Y; Cai Q; Jiang W; Sun J; Yuan Y Int Immunopharmacol; 2018 May; 58():186. PubMed ID: 29599101 [No Abstract] [Full Text] [Related]
17. Corrigendum to "Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications" [Int. Immunopharmacol. (2016) 246-250]. Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z Int Immunopharmacol; 2016 Dec; 41():145. PubMed ID: 27612398 [No Abstract] [Full Text] [Related]
18. Corrigendum to 'A randomized controlled, dose-escalation study of SSS07, a humanized rabbit anti-human TNF alpha antibody, in healthy Chinese adults'. [Int. Immunopharmacol. 75 (2019) 105807]. Wang Q; Xie X; Su F; Wang J; Chen S; Wang Q; Jiang D; Wang Y; Zhang T; Liu C; Han M; Tao T; Wu Q; Xi N; Li Z; Song H; Fang Y Int Immunopharmacol; 2020 Oct; 87():106874. PubMed ID: 32792244 [No Abstract] [Full Text] [Related]
19. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275]. Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242 [No Abstract] [Full Text] [Related]
20. Corrigendum to "Integrated population pharmacokinetics of immunoglobulin G following intravenous or subcutaneous administration of various immunoglobulin products in patients with primary immunodeficiencies" [Int. Immunopharmacol. 113(Part A) (2022) 109331]. Li Z; Follman K; Freshwater E; Engler F; Yel L Int Immunopharmacol; 2023 Jan; 114():109555. PubMed ID: 36527876 [No Abstract] [Full Text] [Related] [Next] [New Search]